Combination of Omacetaxine Mepesuccinate (homoharringtonine) and Sorafenib As an Effective Regimen for Acute Myeloid Leukemia (AML) Carrying FLT3-ITD

被引：0
|
作者：
Leung, Garret M. K.
Zhang, Chunxiao
To, Alan W. L.
Lam, Stephen S. Y.
Kwong, Yok Lam
Leung, Anskar
机构：
来源：
BLOOD | 2017年 / 130卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
3849
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Homoharringtonine (omacetaxine mepesuccinate) as an adjunct for FLT3-ITD acute myeloid leukemia
    Lam, Stephen S. Y.
    Ho, Eric S. K.
    He, Bai-Liang
    Wong, Wui-Wing
    Cher, Chae-Yin
    Ng, Nelson K. L.
    Man, Cheuk-Him
    Gill, Harinder
    Cheung, Alice M. S.
    Ip, Ho-Wan
    So, Chi-Chiu
    Tamburini, Jerome
    So, Chi Wai Eric
    Ho, Dona N.
    Au, Chun-Hang
    Chan, Tsun-Leung
    Ma, Edmond S. K.
    Liang, Raymond
    Kwong, Yok-Lam
    Leung, Anskar Y. H.
    SCIENCE TRANSLATIONAL MEDICINE, 2016, 8 (359)
  • [2] The Combination Effect of Homoharringtonine and Ibrutinib on FLT3-ITD Mutant Acute Myeloid Leukemia
    Li, Xia
    Yin, Xiufeng
    Wang, Huafeng
    Huang, Jiansong
    Yu, Mengxia
    Ma, Zhixin
    Li, Chenying
    Zhou, Yile
    Yan, Xiao
    Huang, Shujuan
    Jin, Jie
    BLOOD, 2016, 128 (22)
  • [3] The combination effect of homoharringtonine and ibrutinib on FLT3-ITD mutant acute myeloid leukemia
    Li, Xia
    Yin, Xiufeng
    Wang, Huafeng
    Huang, Jiansong
    Yu, Mengxia
    Ma, Zhixin
    Li, Chenying
    Zhou, Yile
    Yan, Xiao
    Huang, ShuJuan
    Jin, Jie
    ONCOTARGET, 2017, 8 (08) : 12764 - 12774
  • [4] A novel combination regimen of BET and FLT3 inhibition for FLT3-ITD acute myeloid leukemia
    Lee, Lauren
    Hizukuri, Yoshiyuki
    Severson, Paul
    Powell, Benjamin
    Zhang, Chao
    Ma, Yan
    Narahara, Maiko
    Sumi, Hiroyuki
    Hernandez, Daniela
    Rajkhowa, Trivikram
    Bollag, Gideon
    Levis, Mark
    HAEMATOLOGICA, 2021, 106 (04) : 1022 - 1033
  • [5] A Novel Combination Regimen of BET and FLT3 Inhibition for FLT3-ITD Acute Myeloid Leukemia
    Lee, Lauren
    Hizukuri, Yoshiyuki
    Severson, Paul
    Powell, Ben
    Zhang, Chao
    Ma, Yan
    Narahara, Maiko
    Sumi, Hiroyuki
    Bollag, Gideon
    Levis, Mark J.
    BLOOD, 2019, 134
  • [6] Secondary resistance to sorafenib in two patients with acute myeloid leukemia (AML) harboring FLT3-ITD mutations
    Scholl, Sebastian
    Spies-Weisshart, Baerbel
    Klink, Anne
    Muegge, Lars-Olof
    Fricke, Hans-Joerg
    Hochhaus, Andreas
    ANNALS OF HEMATOLOGY, 2011, 90 (04) : 473 - 475
  • [7] Secondary resistance to sorafenib in two patients with acute myeloid leukemia (AML) harboring FLT3-ITD mutations
    Sebastian Scholl
    Baerbel Spies-Weisshart
    Anne Klink
    Lars-Olof Muegge
    Hans-Joerg Fricke
    Andreas Hochhaus
    Annals of Hematology, 2011, 90 : 473 - 475
  • [8] Treatment of FLT3-ITD acute myeloid leukemia
    Fathi, Amir T.
    Chen, Yi-Bin
    AMERICAN JOURNAL OF BLOOD RESEARCH, 2011, 1 (02): : 175 - 189
  • [9] Sorafenib in combination with chemotherapy as first-line therapy for FLT3-ITD positive acute myeloid leukemia
    张青玉
    ChinaMedicalAbstracts(InternalMedicine), 2017, 34 (03) : 182 - 182
  • [10] Pyruvate Dehydrogenase (PDH) Activity Is a Source of Resistance to Sorafenib in FLT3-ITD Expressing Acute Myeloid Leukemia (AML)
    Anderson, Rebecca G.
    Pladna, Kristin M.
    Pardee, Timothy S.
    BLOOD, 2017, 130
12345